T 0179/16 (Sustained release risperidone formulation / DURECT) of 15.11.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T017916.20211115
- Date of decision
- 15 November 2021
- Case number
- T 0179/16
- Petition for review of
- -
- Application number
- 11162857.4
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Sustained release small molecule drug formulation
- Applicant name
- Durect Corporation
- Opponent name
- Generics [UK] Limited
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a)European Patent Convention Art 123(2)European Patent Convention Art 56European Patent Convention Art 76(1)
- Keywords
- Inventive step - main request, auxiliary requests 1-2 (no)
Inventive step - auxiliary request 4 (yes)
Divisional application - added subject-matter (auxiliary request 3: yes, auxiliary request 4: no) - Catchword
- -
- Cited cases
- -
- Citing cases
- G 0002/21
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the Opposition Division with the order to maintain the patent on the basis of auxiliary request 4 filed with letter dated 12 August 2016 and a description to be adapted thereto.